Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Denali Therapeutics Inc (NASDAQ: DNLI) closed at $24.21 in the last session, down -0.70% from day before closing price of $24.38. In other words, the price has decreased by -$0.70 from its previous closing price. On the day, 0.62 million shares were traded. DNLI stock price reached its highest trading level at $24.8 during the session, while it also had its lowest trading level at $23.99.
Ratios:
We take a closer look at DNLI’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 11.79 and its Current Ratio is at 11.79. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on December 13, 2023, initiated with a Buy rating and assigned the stock a target price of $32.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 01 ’24 when Krognes Steve E. sold 30,000 shares for $22.12 per share. The transaction valued at 663,668 led to the insider holds 34,404 shares of the business.
SATO VICKI L sold 3,080 shares of DNLI for $68,204 on Jul 01 ’24. The Director now owns 119,256 shares after completing the transaction at $22.14 per share. On Jun 13 ’24, another insider, Krognes Steve E., who serves as the Director of the company, sold 688 shares for $21.79 each. As a result, the insider received 14,992 and left with 52,620 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DNLI now has a Market Capitalization of 3452563456 and an Enterprise Value of 2566241792. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.69 while its Price-to-Book (P/B) ratio in mrq is 2.37. Its current Enterprise Value per Revenue stands at 8.688 whereas that against EBITDA is -12.386.
Stock Price History:
Over the past 52 weeks, DNLI has reached a high of $28.75, while it has fallen to a 52-week low of $14.56. The 50-Day Moving Average of the stock is 12.39%, while the 200-Day Moving Average is calculated to be 23.81%.
Shares Statistics:
According to the various share statistics, DNLI traded on average about 1.19M shares per day over the past 3-months and 1010480 shares per day over the past 10 days. A total of 138.39M shares are outstanding, with a floating share count of 117.19M. Insiders hold about 17.82% of the company’s shares, while institutions hold 81.52% stake in the company. Shares short for DNLI as of 1721001600 were 7085513 with a Short Ratio of 5.96, compared to 1718323200 on 8856582. Therefore, it implies a Short% of Shares Outstanding of 7085513 and a Short% of Float of 5.82.
